These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 35804809)

  • 1. Prognostic MicroRNA Panel for HCV-Associated HCC: Integrating Computational Biology and Clinical Validation.
    Dabbish AM; Abdelzaher HM; Abohawya M; Shamma S; Mahmoud YH; Maged A; Manaa M; Hassany M; Kobeissy F; Bazgir O; El-Fawal H; Azzazy HME; Abdelnaser A
    Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating miRNA-122, miRNA-199a, and miRNA-16 as Biomarkers for Early Detection of Hepatocellular Carcinoma in Egyptian Patients with Chronic Hepatitis C Virus Infection.
    El-Abd NE; Fawzy NA; El-Sheikh SM; Soliman ME
    Mol Diagn Ther; 2015 Aug; 19(4):213-20. PubMed ID: 26133725
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum microRNA panels as potential biomarkers for early detection of hepatocellular carcinoma on top of HCV infection.
    Zekri AN; Youssef AS; El-Desouky ED; Ahmed OS; Lotfy MM; Nassar AA; Bahnassey AA
    Tumour Biol; 2016 Sep; 37(9):12273-12286. PubMed ID: 27271989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-122a as a non-invasive biomarker for HCV genotype 4-related hepatocellular carcinoma in Egyptian patients.
    El-Ahwany EGE; Mourad L; Zoheiry MMK; Abu-Taleb H; Hassan M; Atta R; Hassanien M; Zada S
    Arch Med Sci; 2019 Oct; 15(6):1454-1461. PubMed ID: 31749873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA signature in patients with hepatocellular carcinoma associated with type 2 diabetes.
    Elemeery MN; Mohamed MA; Madkour MA; Shamseya MM; Issa NM; Badr AN; Ghareeb DA; Pan CH
    World J Gastroenterol; 2019 Nov; 25(42):6322-6341. PubMed ID: 31754293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implication of miR-122, miR-483, and miR-335 Expression Levels as Potential Signatures in HCV-Related Hepatocellular Carcinoma (HCC) in Egyptian Patients.
    Elfert AY; Salem A; Abdelhamid AM; Salama A; Sourour DA; Shaker O; Keshk M
    Front Mol Biosci; 2022; 9():864839. PubMed ID: 35651814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum microRNA expression profiling identifies serum biomarkers for HCV-related hepatocellular carcinoma.
    Li J; Jin B; Wang T; Li W; Wang Z; Zhang H; Song Y; Li N
    Cancer Biomark; 2019; 26(4):501-512. PubMed ID: 31658041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic and prognostic roles of circulating miRNA-223-3p in hepatitis B virus-related hepatocellular carcinoma.
    Pratedrat P; Chuaypen N; Nimsamer P; Payungporn S; Pinjaroen N; Sirichindakul B; Tangkijvanich P
    PLoS One; 2020; 15(4):e0232211. PubMed ID: 32330203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of circulating miR-182 and miR-150 as biomarkers for cirrhosis and hepatocellular carcinoma post HCV infection in Egyptian patients.
    Shaheen NMH; Zayed N; Riad NM; Tamim HH; Shahin RMH; Labib DA; ELsheikh SM; Moneim RA; Yosry A; Khalifa RH
    Virus Res; 2018 Aug; 255():77-84. PubMed ID: 30003924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis C Virus-Induced Upregulation of MicroRNA miR-146a-5p in Hepatocytes Promotes Viral Infection and Deregulates Metabolic Pathways Associated with Liver Disease Pathogenesis.
    Bandiera S; Pernot S; El Saghire H; Durand SC; Thumann C; Crouchet E; Ye T; Fofana I; Oudot MA; Barths J; Schuster C; Pessaux P; Heim MH; Baumert TF; Zeisel MB
    J Virol; 2016 Jul; 90(14):6387-6400. PubMed ID: 27147737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression analysis of liver-specific circulating microRNAs in HCV-induced hepatocellular Carcinoma in Egyptian patients.
    Mourad L; El-Ahwany E; Zoheiry M; Abu-Taleb H; Hassan M; Ouf A; Rahim AA; Hassanien M; Zada S
    Cancer Biol Ther; 2018 May; 19(5):400-406. PubMed ID: 29333940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying Differentially Expressed MicroRNAs Between Cirrhotic and Non-Cirrhotic Hepatocellular Carcinoma and Exploring Their Functions Using Bioinformatic Analysis.
    Mei Y; You Y; Xia J; Gong JP; Wang YB
    Cell Physiol Biochem; 2018; 48(4):1443-1456. PubMed ID: 30064138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of a serum microRNA panel as biomarkers for early diagnosis of hepatocellular carcinoma post-hepatitis C infection in Egyptian patients.
    Elemeery MN; Badr AN; Mohamed MA; Ghareeb DA
    World J Gastroenterol; 2017 Jun; 23(21):3864-3875. PubMed ID: 28638226
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum microRNA let-7a-1/let-7d/let-7f and miRNA 143/145 Gene Expression Profiles as Potential Biomarkers in HCV Induced Hepatocellular Carcinoma.
    Aly DM; Gohar NA; Abd El-Hady AA; Khairy M; Abdullatif MM
    Asian Pac J Cancer Prev; 2020 Feb; 21(2):555-562. PubMed ID: 32102538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comprehensive evaluation of microRNA as a biomarker for the diagnosis of hepatocellular carcinoma.
    Malik J; Klammer M; Rolny V; Chan HL; Piratvisuth T; Tanwandee T; Thongsawat S; Sukeepaisarnjaroen W; Esteban JI; Bes M; Köhler B; Swiatek-de Lange M
    World J Gastroenterol; 2022 Aug; 28(29):3917-3933. PubMed ID: 36157551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
    Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
    Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum MicroRNAs as Potential Biomarkers for Early Diagnosis of Hepatitis C Virus-Related Hepatocellular Carcinoma in Egyptian Patients.
    Motawi TK; Shaker OG; El-Maraghy SA; Senousy MA
    PLoS One; 2015; 10(9):e0137706. PubMed ID: 26352740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating microRNAs panel as a diagnostic tool for discrimination of HCV-associated hepatocellular carcinoma.
    Ali HEA; Abdel Hameed R; Effat H; Ahmed EK; Atef AA; Sharawi SK; Ali M; Abd Elmageed ZY; Abdel Wahab AH
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):e51-e62. PubMed ID: 28750770
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulatory miRNA-484, 524, 615 and 628 expression profiling in HCV mediated HCC among Egyptian patients; implications for diagnosis and staging of hepatic cirrhosis and fibrosis.
    El-Maraghy SA; Adel O; Zayed N; Yosry A; El-Nahaas SM; Gibriel AA
    J Adv Res; 2020 Mar; 22():57-66. PubMed ID: 31956442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNAs (miR-21, miR-223, miR-885-5p) along the clinical spectrum of HCV-related chronic liver disease in Egyptian patients.
    Nasser MZ; Zayed NA; Mohamed AM; Attia D; Esmat G; Khairy A
    Arab J Gastroenterol; 2019 Dec; 20(4):198-204. PubMed ID: 31806407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.